Journal decision profile

Redox Biology

Medicine · Biochemistry, Genetics and Molecular Biology

Redox Biology's 2026 Journal Metrics Score is 13.2, ranking Q1 in Molecular Biology and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

Elsevier BVNetherlandspISSN 2213-2317eISSN 2213-2317
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
13.2

Journal Metrics Score 2026 · 2021–2024 window citedness 14.05.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
46 daysmedian

Middle 50%: 27–68 days

95 of 100 PubMed-indexed articles · 95% coverage · 2024–2025

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$3,900

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Redox Biology?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
13.22026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#196 / 1,723LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
58.7%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
3.38MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
46 daysIQR 27–68 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
400 / yr2021–2024 AVG
Field-normalized top 10% share58.7%

939 of 1,601 works · same type, year & subfield

Field-normalized top 1% share13.9%

223 works · same type, year & subfield

Median FWCI3.38×

Above field-year expectation

Source output rank#196

of 1,723 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 3.38, so its typical recent paper runs about 238% above its field benchmark.

What does Top 10% Share mean?

58.7% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

1412016
2962017
2622018
2992019
4382020
3672021
3582022
4172023
4592024
5062025

Recent work-type mix

1,601 OpenAlex works · 2021–2024

Article94.4%
Erratum4.3%
Retraction0.6%
Review0.3%
Editorial0.2%
Other0.1%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Redox Biology publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Ferroptosis and cancer prognosis105
Genomics, phytochemicals, and oxidative stress69
Mitochondrial Function and Pathology65
Redox biology and oxidative stress64
Sulfur Compounds in Biology58
Neutrophil, Myeloperoxidase and Oxidative Mechanisms36
Adipose Tissue and Metabolism30
Autophagy in Disease and Therapy30
RNA modifications and cancer28
Selenium in Biological Systems27
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 1,601 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Molecular BiologyQ1
Pulmonary and Respiratory MedicineQ1
Q1
Subfield Quartile
B1
CAS Block

Ranking and source check

#67
of 3,784 Biology & Basic Science field journals
#67
among Q1 Biology & Basic Science journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
4,323
H-Index
209
Fully Open Access
Yes
Recent OA Works
4,308
Subject Areas
Molecular BiologyPulmonary and Respiratory Medicine

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Common questions about Redox Biology

What is Redox Biology's Journal Metrics Score in 2026?

Redox Biology's 2026 Journal Metrics Score is 13.2, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What quartile is Redox Biology in?

Redox Biology's best quartile is Q1. By OpenAlex subfield: Q1 in Molecular Biology; Q1 in Pulmonary and Respiratory Medicine. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Redox Biology will not match this score exactly. Compare journals using one source at a time.

How long does Redox Biology take from submission to acceptance?

Across 95 recent PubMed records with both dates, Redox Biology took a median of 46 days from submission to acceptance; the middle half took 27–68 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.

How much does it cost to publish in Redox Biology?

OpenAlex lists an indicative article processing charge of $3,900 USD for Redox Biology. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Redox Biology?

Comparable journals include Free Radical Biology and Medicine, Antioxidants & Redox Signaling, Apoptosis, and Biochimica Et Biophysica Acta-Molecular Basis of Disease. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

Cite an article from this journal
Back to Search